Precise targeting and dosing are critical for neurophysiological effectivity of repetitive transcranial magnetic stimulation (rTMS), particularly in clinical applications such as treating major depressive disorder (MDD). While neuronavigation enables accurate, individualized coil positioning, even small deviations in coil placement, e.g. during extended stimulation protocols, can significantly alter the induced electric field (E-field). In this study, we use continuous neuronavigational monitoring during stimulation to quantify motion-induced E-field variability at the target and introduce a novel methodology for compensating it.

Interleaved TMS-fMRI has advanced understanding of network modulation but is limited to hemodynamic measures. We introduce a novel interleaved TMS-MRS platform, using standard MRI hardware, to assess real-time neurochemical changes and demonstrate feasibility in a clinical sample of patients with treatment-resistant depression (TRD).

Brain targets for transcranial magnetic stimulation (TMS) are often derived from anatomical landmarks or group-level neuroimaging data, which lack precision or personalization, contributing to the variability in TMS responses. Personalized functional magnetic resonance imaging (fMRI) may improve accuracy but remains resource-intensive and not widely accessible.

Transcranial magnetic stimulation (TMS) is a widely used non-invasive brain stimulation technique, but the neural circuits activated by TMS remain poorly understood. Previous modeling approaches have been limited to either simplified point-neuron networks or isolated single-cell models that lack synaptic connectivity.

The use of photobiomodulation (PBM) to enhance brain health, specifically glymphatic drainage and thus neurotoxic waste clearance, may make it a promising therapeutic tool against neurodegenerative diseases such as Alzheimer's disease.

The nucleus reuniens (RE) is a midline thalamic nucleus interconnecting the medial prefrontal cortex (mPFC) and the hippocampus (HPC), structures known to be involved in aversive memory processes. Recent work indicates that the RE plays a critical role in the acquisition and retrieval of fear extinction memories. Functional inactivation of the RE impairs both mPFC-HPC coherence and extinction memory. Here we examine whether imposing theta activity on the RE entrains oscillations in the mPFC and HPC and facilitates extinction learning.

Transcranial magnetic stimulation (TMS) is increasingly used off-label for posttraumatic stress disorder (PTSD), often applying protocols developed for depression. While prior studies suggest high-frequency TMS can improve PTSD symptoms, few have been adequately powered to compare protocols. We examined whether three common TMS protocols yield equivalent outcomes for PTSD in a large, multisite cohort of veterans.

Deep brain stimulation (DBS) of the subthalamic region is an established therapy for the treatment of Parkinson's disease (PD). Computational models of subthalamic DBS are commonly used in the clinical literature to estimate the brain connections activated by the stimulus. However, those analyses are typically performed with simplified DBS modeling methods. As subthalamic DBS research evolves, there is a need for more advanced modeling results.

Focused ultrasound (FUS) is a rapidly advancing noninvasive energy delivery technology with the capacity to precisely modulate the tumor microenvironment (TME) through acoustic waves. Glioblastoma (GBM) is characterized by profound TME immune suppression and treatment resistance and has emerged as a key subject to treatment with FUS therapy.

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique mainly used in humans, in which weak direct currents are applied over the scalp to alter cortical excitability and induce neuroplasticity. Previous studies have demonstrated the value of tDCS for modulating sensory, motor, and cognitive functions, nevertheless, knowledge about how externally applied electric fields affect different components of neuronal networks is still incomplete, and in vivo animal models, which are required for a deeper understanding, are not fully developed. To evaluate the impact of tDCS on cortical excitability, many human experiments assess motor evoked potentials elicited by motor cortex (M1) stimulation.